Zhuo, L.; Ma, M.; Zhang, J.; Zhou, J.; Zheng, Y.; Liang, A.; Sun, Q.; Liu, J.; Liao, W.
Qifu Decoction Alleviates Lipopolysaccharide-Induced Myocardial Dysfunction by Inhibiting TLR4/NF-κB/NLRP3 Inflammatory Pathway and Activating PPARα/CPT Pathway. Pharmaceuticals 2025, 18, 1109.
https://doi.org/10.3390/ph18081109
AMA Style
Zhuo L, Ma M, Zhang J, Zhou J, Zheng Y, Liang A, Sun Q, Liu J, Liao W.
Qifu Decoction Alleviates Lipopolysaccharide-Induced Myocardial Dysfunction by Inhibiting TLR4/NF-κB/NLRP3 Inflammatory Pathway and Activating PPARα/CPT Pathway. Pharmaceuticals. 2025; 18(8):1109.
https://doi.org/10.3390/ph18081109
Chicago/Turabian Style
Zhuo, Lingxin, Mingxuan Ma, Jiayi Zhang, Jiayu Zhou, Yuqi Zheng, Aiyin Liang, Qingqing Sun, Jia Liu, and Wenting Liao.
2025. "Qifu Decoction Alleviates Lipopolysaccharide-Induced Myocardial Dysfunction by Inhibiting TLR4/NF-κB/NLRP3 Inflammatory Pathway and Activating PPARα/CPT Pathway" Pharmaceuticals 18, no. 8: 1109.
https://doi.org/10.3390/ph18081109
APA Style
Zhuo, L., Ma, M., Zhang, J., Zhou, J., Zheng, Y., Liang, A., Sun, Q., Liu, J., & Liao, W.
(2025). Qifu Decoction Alleviates Lipopolysaccharide-Induced Myocardial Dysfunction by Inhibiting TLR4/NF-κB/NLRP3 Inflammatory Pathway and Activating PPARα/CPT Pathway. Pharmaceuticals, 18(8), 1109.
https://doi.org/10.3390/ph18081109
